US45166A1025 - IDYA - A2PJPB (XNAS)
IDEAYA BIOSCIENCES INC Aktie
35,99 USD
Aktuelle Kurse von IDEAYA BIOSCIENCES INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
IDYA
|
USD
|
19.09.2024 18:20
|
35,99 USD
| 35,02 USD | 2,77 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
2,77 % | -0,33 % | -5,26 % | -4,51 % | -17,19 % | 24,79 % | 229,88 % |
Firmenprofil zu IDEAYA BIOSCIENCES INC Aktie
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Investierte Fonds
Folgende Fonds haben in IDEAYA BIOSCIENCES INC investiert:
Fonds | Vol. in Mio 33,27 | Anteil (%) 0,08 % |
Unternehmensdaten zur IDEAYA BIOSCIENCES INC Aktie
Name IDEAYA BIOSCIENCES INC
Firma IDEAYA Biosciences, Inc.
Symbol IDYA
Website https://www.ideayabio.com
Heimatbörse
NASDAQ
WKN A2PJPB
ISIN US45166A1025
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Yujiro S. Hata
Marktkapitalisierung 3 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 7000 Shoreline Court, 94080 South San Francisco
IPO Datum 2019-05-23
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 30J.F |
NASDAQ | IDYA |
Weitere Aktien
Investoren die IDEAYA BIOSCIENCES INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024